EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations
Go back to EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations| (AMEX: MKKGY) | Delayed: 32.48 -0.72 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.20 | 52 Week High | $ | |||
| Open | $32.56 | 52 Week Low | $ | |||
| Day High | $32.60 | P/E | N/A | |||
| Day Low | $32.20 | EPS | $ | |||
| Volume | 41,898 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 130.42 -0.5 (0.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.92 | 52 Week High | $65.46 | |||
| Open | $129.93 | 52 Week Low | $47.97 | |||
| Day High | $132.84 | P/E | 88.72 | |||
| Day Low | $129.70 | EPS | $1.47 | |||
| Volume | 6,343,840 | |||||
